Discovery of ONO-8590580: A Novel, Potent and Selective GABAA Α5 Negative Allosteric Modulator for the Treatment of Cognitive Disorders

A. Lewis, A. Beresford,M. S. Chambers, G. Clark, D. C. Hartley,K. L. Hirst, M. Higashino, S. Kawahadara, M. Nakanishi,T. Saito,A. Imagawa, H. Habashita, S. Maidment,A. M. Macleod,A. P. Owens, A. Rae, C. Rouse, G. Wishart

Bioorganic & medicinal chemistry letters（2020）

引用 2|浏览28

暂无评分

摘要

The identification and SAR development of a series of negative allosteric modulators of the GABAA α5 receptor is described. This novel series of compounds was optimised to provide analogues with high GABAA α5 binding affinity, high α5 negative allosteric modulatory activity, good functional subtype selectivity and low microsomal turnover, culminating in identification of ONO-8590580.

查看译文

关键词

GABAA alpha 5,Negative allosteric modulator,Cognition enhancement,ONO-8590580

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要